Kodiak Sciences (KOD) Profit After Tax (2017 - 2026)
Kodiak Sciences (KOD) posted Profit After Tax of -$58.2 million for Q1 2026, down 133.58% on a QoQ basis from $173.2 million in Q4 2025, and down 1.21% year-over-year from -$58.9 million in Q1 2025.
Kodiak Sciences (KOD) Profit After Tax (2017 - 2026) Analysis & Trends
Kodiak Sciences' Profit After Tax history runs 10 years deep, the most recent figure standing at -$58.2 million for Q1 2026.
- Quarterly Profit After Tax fell 1.21% year-over-year to -$58.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$728000.0 (up 99.62% YoY) and the FY2024 annual result came in at -$176.2 million, up 32.36% from the prior year.
- Profit After Tax was -$58.2 million for Q1 2026 at Kodiak Sciences, down from $173.2 million in the prior quarter.
- Across five years, Profit After Tax topped out at $262.1 million in Q4 2022 and bottomed at -$95.7 million in Q1 2022.
- A 5-year average of -$13.1 million and a median of -$44.6 million in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax sank 10283.33% — and 2025, when it jumped 492.76%.
- Kodiak Sciences' Profit After Tax stood at $262.1 million in 2022, then sank by 123.21% to -$60.8 million in 2023, then rose by 27.5% to -$44.1 million in 2024, then soared by 492.76% to $173.2 million in 2025, then sank by 133.58% to -$58.2 million in 2026.
- Business Quant data shows KOD's Profit After Tax at -$58.2 million in Q1 2026, $173.2 million in Q4 2025, and -$61.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | -58.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.16 Mn |
| Dec 31, 2025 | 173.20 Mn |
| Sep 30, 2025 | -61.46 Mn |
| Jun 30, 2025 | -54.31 Mn |
| Mar 31, 2025 | -57.46 Mn |
| Dec 31, 2024 | -44.10 Mn |
| Sep 30, 2024 | -43.95 Mn |
| Jun 30, 2024 | -45.12 Mn |
| Mar 31, 2024 | -43.04 Mn |
| Dec 31, 2023 | -60.82 Mn |
| Jun 30, 2023 | -80.19 Mn |
| Mar 31, 2023 | 1.21 Mn |
| Dec 31, 2022 | 262.07 Mn |
| Sep 30, 2022 | -636,000.00 |
| Jun 30, 2022 | -1.87 Mn |
| Mar 31, 2022 | -95.71 Mn |
| Dec 31, 2021 | -93.17 Mn |
| Sep 30, 2021 | -67.53 Mn |
| Jun 30, 2021 | -18,000.00 |
| Mar 31, 2021 | -50.45 Mn |